Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Share-based Compensation (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Share-based Compensation for 6 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation changed N/A to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $9.2 million for FY2025, 73.66% up from the prior year.
  • Share-based Compensation for Q4 2025 was $5.1 million at Actinium Pharmaceuticals, down from $8.9 million in the prior quarter.
  • The five-year high for Share-based Compensation was $8.9 million in Q1 2025, with the low at -$1.2 million in Q4 2021.
  • Average Share-based Compensation over 5 years is $1.5 million, with a median of $970000.0 recorded in 2022.
  • The sharpest move saw Share-based Compensation decreased 7.41% in 2022, then skyrocketed 543.98% in 2025.
  • Over 5 years, Share-based Compensation stood at -$1.2 million in 2021, then soared by 179.59% to $979000.0 in 2022, then dropped by 5.31% to $927000.0 in 2023, then soared by 44.23% to $1.3 million in 2024, then soared by 281.53% to $5.1 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $5.1 million, $8.9 million, and $1.3 million for Q4 2025, Q1 2025, and Q3 2024 respectively.